A high neonatal serum eosinophil cationic protein level is a risk factor for atopic symptoms

Acta Paediatrica, International Journal of Paediatrics

Volumn 93, Issue 6, 2004, Pages 765-769

  Monti, G ^a   Peltran, A ^a   Coscia, A ^a   Bertino, E ^a   Ferrero, L ^a   Savant Levet, P ^b   Guala, G ^b   Altare, F ^c   Russo, R ^a   Fabris, C ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b MARIA VITTORIA HOSPITAL   (Italy)

^c SANT ANNA HOSPITAL   (Italy)

Author keywords

Allergy prediction and prevention; Atopy; Eosinophil; Eosinophil cationic protein; Newborn

Indexed keywords

CATION; EOSINOPHIL CATIONIC PROTEIN; PROTEIN;

ARTICLE; ATOPY; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL PRACTICE; DIET; ENVIRONMENTAL FACTOR; EOSINOPHIL; FAMILY HISTORY; FOLLOW UP; HEREDITY; HIGH RISK POPULATION; HUMAN; INTERMETHOD COMPARISON; MEASUREMENT; MULTIVARIATE ANALYSIS; NEWBORN; PRIORITY JOURNAL; RISK FACTOR; SIBLING; STATISTICAL SIGNIFICANCE; STUDENT T TEST;

BLOOD PROTEINS; EOSINOPHIL GRANULE PROTEINS; HUMANS; HYPERSENSITIVITY, IMMEDIATE; INFANT, NEWBORN; PREDICTIVE VALUE OF TESTS; RADIOALLERGOSORBENT TEST; RIBONUCLEASES; RISK FACTORS;

EID: 2942559008     PISSN: 08035253     EISSN: None     Source Type: Journal    
DOI: 10.1080/08035250410027634     Document Type: Article

References (33)

1. Wahn U, von Mutius E. Childhood risk factors for atopy and the importance of early prevention. J Allergy Clin Immunol 2001; 107: 567-74
2. Kjellman NI, Nilsson L. Is allergy prevention realistic and beneficial? Pediatr Allergy Immunol 1999; 10: 11-7
3. Strimas JH, Chi DS. Significance of IgE level in amniotic fluid and cord blood for the prediction of allergy. Ann Allergy 1988; 61: 133-6
4. Kaan A, Dimich-Ward H, Manfreda J, Becker A, Watson W, Ferguson A, et al. Cord blood IgE: its determinants and prediction of development of asthma and other allergic disorders at 12 months. Ann Allergy Asthma Immunol 2000; 84: 37-42
5. Lilja G, Johansson SGO, Kussofsky E, et al. IgE-levels in cord blood and at 4-5 days of age: relation to clinical symptoms of atopic disease up to 18 months of age. Allergy 1990; 45: 436-44
6. Kim KM, Inoue Y, Uenoyama Y, et al. Prediction of the development of atopic symptoms in early childhood by cord IgE binding factors (soluble Fc epsilon R2). Immunol Lett 1990; 4: 63-8
7. Haus M, Heese H, De V, Weinberg EG, et al. Cord blood eosinophils and platelets as predictive atopic markers. Clin Exp Allergy 1990; 20: 10
8. Borres MP, Einarsson R, Björkstén B. Serum levels of interleukin-4, soluble CD23 and IFN in relation to development of allergic disease during the first 18 months of life. Clin Exp Allergy 1995; 25: 543-8
9. Oymar K, Laerdal A, Bjerknes R. Soluble CD30 and CD23 in cord blood are not related to atopy in early childhood. Pediatr Allergy immunol 2000; 11: 220-4
10. Miadonna A, Tedeschi A, Leggier E, et al. Cord blood releasability: a predictive marker of allergy? Allergy Immunol 1988; 20: 45-7
11. Miles EA, Warner JA, Jones AC, Colwell BM, Bryan TN, Warner JO. Peripheral blood mononuclear cell proliferative response in the first year of life in babies born to allergic parents. Clin Exp Allergy 1996; 26: 780-8
12. van der Velden VH, Laan MP, Baert MR, de Waal Malefyt R, Neijens HJ, Savelkoul HF. Selective development of a strong Th2 cytokine profile in high-risk children who develop atopy: risk factors and regulatory role of IFN-gamma, IL-4 and IL-10. Clin Exp Allergy 2001; 31: 997-1006
13. Lilja G, Öhman H. Prediction of atopic disease in infancy by determination of immunological parameters: IgE, IgE- and IgA antibodies to food allergens, skin prick tests and T-lymphocyte subsets. Pediatr Allergy Immunol 1991; 2: 6-13
14. Odelram H, Björkstén B, Chan SC, Hanifin JM, Kjellman N-IM. Neonatal leukocyte cAMP-phosphodiesterase determination is not suitable for allergy prediction. Allergy 1994; 49: 677-9
15. Yu G, Kjellman N-IM, Björkstén B. Phospholipid fatty acids in cord blood: family history and development of allergy. Acta Paediatr 1996; 85: 679-83
16. Klementson H, Andersson M, Baumgarten CR, et al. Changes in non-specific nasal reactivity and eosinophil influx and activation after allergen challenge. Clin Exp Allergy 1990; 20: 539
17. Halmerbauer G, Frischer T, Koller DY. Monitoring of disease activity by measurement of inflammatory markers in atopic dermatitis in childhood. Allergy 1997; 52: 765-9
18. Sugay T, Sakiyama Y, Matumoto S. Eosinophil cationic protein in peripheral blood of pediatric patients with allergic diseases. Clin Exp Allergy 1992; 22: 275
19. Gebhardt M, Wenzel HC, Hipler UC, Herrmann D, Wollina U. Monitoring of serologic immune parameters in inflammatory skin diseases. Allergy 1997; 52: 1087-94
20. Zubovic I, Rozmanic V, Ahel V, Banac S. Manifold significance of serum eosinophil cationic protein in asthmatic children. Acta Med Croatica 2002; 56: 53-6
21. Osashi Y, Nakai Y, Kanikoki Y, Ohno Y, Okamoto H, Sakamoto H, et al. The effect of immunotherapy on the serum levels of eosinophil cationic protein in seasonal allergic rhinitis. Clinical Otolaryngology 1997; 22: 100-5
22. Calbi M, Giacchetti L. Low breast milk IgA and high blood eosinophil count in breast-fed newborns determine higher risk for developing atopic eczema after an 18-month follow-up. J Investig Allergol Clin Immunol 1998; 8: 161-4
23. Borres MP, Odelram H, Irander K, Kjellman N-IM, Björkstén B. Peripheral blood eosinophilia in infants at 3 months of age is associated with subsequent development of atopic disease in early childhood. J Allergy Clin Immunol 1995; 95: 694-8
24. Reijonen TM, Korppi M, Kuikka L, Savolainen K, Kleemola M, Mononen I, et al. Serum eosinophil cationic protein as a predictor of wheezing after bronchiolitis. Pediatr Pulmonol 1997; 23: 397-400
25. Pifferi M, Ragazzo V, Caramella D, Baldini G. Eosinophil cationic protein in infants with respiratory syncytial virus bronchiolitis: predictive value for subsequent development of persistent wheezing. Pediatr Pulmonol 2001; 31: 419-24
26. Koller DY, Wojnarowski C, Herkner KR, Weinländer G, Raderer M, Eichler I, et al. High levels of eosinophil cationic protein in wheezing infants predict the development of asthma. J Allergy Clin Immunol 1997; 99: 752-6
27. Miyoshi M. Measurements of serum eosinophil cationic protein levels in wheezing infants. Aerugi 2002; 51: 1147-52
28. Visscher MB, Halberg F. Daily rythm in number of circulating eosinophils and some related phenomena. Ann New York Acad Sci 1954; 59: 834-6
29. Rolfe FG, Hughes JM, Armour CL, Sewell WA. Inhibition of interleukin-5 gene expression by dexamethasone. Immunology 1992; 77: 494-9
30. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Dermatol Venereol 1980; Suppl 92: 44-7
31. Hattevig G, Kjellman B, Sigurs N, Björkstén B, Kjellman N-IM. The effect of maternal avoidance of eggs, cow's milk and fish during lactation upon allergic manifestations in infants. Clin Exp Allergy 1989; 19: 27-32
32. Piccinni MP, Maggi E, Romagnani S. Role of hormone-controlled T-cell cytokines in the maintenance of pregnancy. Biochem Soc Trans 2000; 28: 212-5
33. Hansen LG. How do we define the high-risk groups for development of allergic disease? Pediatr Allergy Immunol 1996; 7 Suppl 9: 95-7